Traci Turner
Overview
Explore the profile of Traci Turner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
988
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raal F, Mehta V, Kayikcioglu M, Blom D, Gupta P, Elis A, et al.
Lancet Diabetes Endocrinol
. 2025 Jan;
13(3):178-187.
PMID: 39870096
Background: Lerodalcibep, a small binding anti-PCSK9 protein (adnectin), showed effective LDL cholesterol reduction in heterozygous familial hypercholesterolaemia. We aimed to assess the safety and efficacy of lerodalcibep and evolocumab in...
2.
Gaudet D, Greber-Platzer S, Reeskamp L, Iannuzzo G, Rosenson R, Saheb S, et al.
Eur Heart J
. 2024 Jun;
45(27):2422-2434.
PMID: 38856678
Background And Aims: Homozygous familial hypercholesterolaemia (HoFH) is a rare genetic disorder characterized by severely elevated LDL cholesterol (LDL-C) and premature atherosclerotic cardiovascular disease. In the pivotal Phase 3 HoFH...
3.
Martin S, Ditmarsch M, Simmons M, Alp N, Turner T, Davidson M, et al.
Eur Heart J Cardiovasc Pharmacother
. 2022 Oct;
9(2):148-155.
PMID: 36307922
Aims: Low-density lipoprotein (LDL-C) lowering is imperative in cardiovascular disease prevention. We aimed to compare accuracy of three clinically-implemented LDL-C equations in a clinical trial of cholesterol ester transfer protein...
4.
Nissen S, Wolski K, Balog C, Swerdlow D, Scrimgeour A, Rambaran C, et al.
JAMA
. 2022 Apr;
327(17):1679-1687.
PMID: 35368052
Importance: Lipoprotein(a) (Lp[a]) is an important risk factor for atherothrombotic cardiovascular disease and aortic stenosis, for which there are no treatments approved by regulatory authorities. Objectives: To assess adverse events...
5.
Raal F, Kallend D, Ray K, Turner T, Koenig W, Wright R, et al.
N Engl J Med
. 2020 Mar;
382(16):1520-1530.
PMID: 32197277
Background: Familial hypercholesterolemia is characterized by an elevated level of low-density lipoprotein (LDL) cholesterol and an increased risk of premature atherosclerotic cardiovascular disease. Monoclonal antibodies directed against proprotein convertase subtilisin-kexin...
6.
Kapuganti A, Turner T, Thomas C
Ment Health Clin
. 2018 Jun;
7(6):271-275.
PMID: 29955533
Introduction: This retrospective cohort study evaluated effects of buprenorphine/naloxone dose and concomitant use of selected sedating medications on treatment outcomes in patients with opioid use disorder. Methods: Patients enrolled in...
7.
Kusters D, Braamskamp M, Langslet G, McCrindle B, Cassiman D, Francis G, et al.
Circulation
. 2018 Feb;
137(6):641-642.
PMID: 29431667
No abstract available.
8.
Braamskamp M, Langslet G, McCrindle B, Cassiman D, Francis G, Gagne C, et al.
Circulation
. 2017 Jun;
136(4):359-366.
PMID: 28592434
Background: Heterozygous familial hypercholesterolemia (HeFH) is an autosomal dominant disorder leading to premature atherosclerosis. Children with HeFH exhibit early signs of atherosclerosis manifested by increased carotid intima-media thickness (IMT). In...
9.
Ray K, Landmesser U, Leiter L, Kallend D, Dufour R, Karakas M, et al.
N Engl J Med
. 2017 Mar;
376(15):1430-1440.
PMID: 28306389
Background: In a previous study, a single injection of inclisiran, a chemically synthesized small interfering RNA designed to target PCSK9 messenger RNA, was found to produce sustained reductions in low-density...
10.
Braamskamp M, Langslet G, McCrindle B, Cassiman D, Francis G, Gagne C, et al.
J Clin Lipidol
. 2015 Dec;
9(6):741-750.
PMID: 26687694
Objective: Heterozygous familial hypercholesterolemia (HeFH) is an autosomal dominant disorder leading to premature atherosclerosis. Guidelines recommend initiating statins early to reduce low-density lipoprotein cholesterol (LDL-C). Studies have evaluated rosuvastatin in...